We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mortality Associated with Hepatitis C Exceeded That of HIV

By HospiMedica International staff writers
Posted on 14 Dec 2011
A new study reveals that he declining death rate from HIV has been eclipsed by the rising mortality rate associated with hepatitis C infection.

Researchers at the US Centers for Disease Prevention and Control (CDC; Atlanta, GA, USA) examined the US national multiple-cause mortality data for 1999-2007--in all about 21.8 million records--for any mention of hepatitis B virus (HBV), hepatitis C virus (HCV), and, for comparison, HIV infection. More...
They then assessed age-adjusted mortality rates, proportions of select sociodemographic characteristics, and potentially preventable comorbidities in HBV and HCV infected decedents in 2007.

The results showed that the HBV-related death rate was almost constant, while deaths associated with HCV increased significantly to a total of 15,106 deaths in 2007; by comparison, HIV deaths declined to 12,734 deaths in 2007. Comorbidities associated with increased odds of HCV-related mortality included chronic liver disease; hepatitis B coinfection; alcohol-related conditions; and HIV coinfection. Of the HCV-related deaths, 73.4% occurred among persons aged 45-64 years; most deaths in HBV-infected persons also occurred in this age group (59.4%). Factors increasing the odds of HBV-related death included Asian/Pacific Islander identity, chronic liver disease, HCV coinfection, HIV coinfection, and alcohol-related conditions. The study was presented at the annual meeting of the American Association for the Study of Liver Diseases, held during November 2011 in San Francisco (CA, USA).

“There has been a rapidly increasing number of deaths among HCV-infected persons, deaths that now surpass those among HIV-infected persons,” concluded lead author Scott Holmberg, MD, and colleagues of the CDC. “The relatively young age of most HCV-infected persons who are dying--i.e., 45-64 years old--portends a large and increasing health care burden.”

Hepatitis C, also known as non-A and non-B hepatitis, is the most common chronic blood-borne infection in the United States and is the leading indication for liver transplants. While 15%-45% of those infected with HCV are able to clear the virus from their blood within about 6 months from the time of infection, the rest do not, and suffer from chronic (long-term) hepatitis C. About 70% of chronically infected persons will develop chronic liver disease, and between 1% and 5% of chronically infected patients may die from chronic liver disease.

Related Links:
US Centers for Disease Prevention and Control




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.